Search Results for "1"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for 1. Results 2351 to 2360 of 2605 total matches.
Reading Machines For The Blind
The Medical Letter on Drugs and Therapeutics • Feb 21, 1992 (Issue 864)
. Copyright 1988-2002. The Medical Letter, Inc.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http ...
Electronic reading machines that convert print into speech have become increasingly useful for blind, other visually impaired, or dyslexic patients. Some of these devices are available as components that can be added to a personal computer.
EDTA Chelation Therapy for Atherosclerotic Cardiovascular Disease
The Medical Letter on Drugs and Therapeutics • May 27, 1994 (Issue 923)
. Copyright 1988-2002. The Medical Letter, Inc.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http ...
The Medical Letter continues to receive inquiries about the value of edetate disodium (EDTA) chelation therapy for cardiovascular disease. The last Medical Letter article on this subject was published in 1981 (volume 23, page 51). Some authors have estimated that more than 500,000 people receive this form of treatment each year (MT Grier and DG Meyers, Ann Pharmacother, 27:1504, Dec 1993).
Oral Pilocarpine for Xerostomia
The Medical Letter on Drugs and Therapeutics • Aug 19, 1994 (Issue 929)
resulting from any error, inaccuracy or omission. Copyright 1988-2002. The Medical Letter, Inc.
Phone: 1 ...
Pilocarpine hydrochloride (Salagen- MGI Pharma), a cholinergic agonist long available in an ophthalmic formulation for treatment of glaucoma (Pilocar, and others), was recently approved by the US Food and Drug Administration (FDA) for oral treatment of radiation-induced xerostomia (dry mouth) in patients with head and neck cancer.
Sevoflurane for General Anesthesia
The Medical Letter on Drugs and Therapeutics • Oct 27, 1995 (Issue 960)
.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com
The Medical Letter, Vol ...
Sevoflurane (Ultane - Abbott), a volatile liquid fluorocarbon anesthetic delivered as an inhaled vapor, has been approved by the US Food and Drug Administration for induction and maintenance of general anesthesia. It is being marketed as a rapidly eliminated anesthetic suitable for inpatient and outpatient surgery.
Dehydroepiandrosterone (DHEA)
The Medical Letter on Drugs and Therapeutics • Oct 11, 1996 (Issue 985)
.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com
The Medical Letter, Vol ...
Dehydroepiandrosterone (DHEA) is an adrenal androgen now being marketed as a "food supplement"in health food stores. DHEA is not approved for any indication by the US Food and Drug Administration (FDA).
Gemcitabine for Treatment of Pancreatic Cancer
The Medical Letter on Drugs and Therapeutics • Nov 08, 1996 (Issue 987)
. The Medical Letter, Inc.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com ...
Gemcitabine (jem site a been) hydrochloride (Gemzar - Lilly), a nucleoside analog, has been approved by the US Food and Drug Administration for intravenous (IV) use in the first-line treatment of locally advanced or metastatic adenocarcinoma of the pancreas and in patients with pancreatic cancer previously treated with fluorouracil (Adrucil, and others). No previously available drug has had more than minor activity in treating this disease.
Donepezil (Aricept) for Alzheimer's Disease
The Medical Letter on Drugs and Therapeutics • Jun 06, 1997 (Issue 1002)
.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB SITE: http://www.medletter.com
The Medical Letter, Vol ...
Donepezil hydrochloride (Aricept - Eisai), a piperidine-based acetylcholinesterase inhibitor, is now being marketed for oral treatment of cognitive symptoms in patients with mild to moderate dementia due to Alzheimer's disease. Donepezil is the second drug approved for this indication; tacrine hydrochloride (Cognex), also an acetylcholinesterase inhibitor, has been available in the USA for four years (Medical Letter, 35:87, 1993).
Pentosan for Interstitial Cystitis
The Medical Letter on Drugs and Therapeutics • Jun 06, 1997 (Issue 1002)
or omission. Copyright 1988-2002. The Medical Letter, Inc.
Phone: 1-800-211-2769 Fax: 1-914-632-1733 WEB ...
Pentosan polysulfate sodium (Elmiron - Baker Norton), a semi-synthetic mucopolysaccharide structurally similar to heparin, has been approved by the US Food and Drug Administration for oral treatment of interstitial cystitis.
Clarification: Half-Life of Heroin
The Medical Letter on Drugs and Therapeutics • Feb 29, 2016 (Issue 1489)
Drugs Ther 2016; 58:1) might be misleading. We
stated that heroin has a half-life of 2-6 minutes, which ...
A reader expressed concern that a statement in our article Naloxone (Narcan) Nasal Spray for Opioid Overdose (Med Lett Drugs Ther 2016; 58:1) might be misleading. We stated that heroin has a half-life of 2-6 minutes, which is correct, but heroin is a prodrug that is rapidly metabolized to 6-acetylmorphine and morphine. The risk of respiratory depression is related to those active metabolites, and it may persist well beyond the clearance of heroin from the blood.
Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
The Medical Letter on Drugs and Therapeutics • Feb 25, 2019 (Issue 1566)
onset of action.1
ACS — Aspirin plus an oral P2Y12 inhibitor is commonly
used for initial treatment ...
The FDA has required manufacturers of the oral P2Y12
platelet inhibitors clopidogrel (Plavix, and generics),
prasugrel (Effient, and generics), and ticagrelor
(Brilinta) to warn in the product labels that the
absorption of these drugs may be delayed or reduced
when taken with an opioid agonist.